China Jo-Jo Drugstores Relaunches Its Corporate English Language Website

2016-02-01 22:00 2214

HANGZHOU, China, February 1, 2016 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading China-based pharmacy with retail, wholesale and online distribution of pharmaceutical and health care products, announced the relaunch of its corporate English language website which can be viewed at

With operations established in 2003, the Company has been publicly trading on Nasdaq since 2010 and is a premium retail and online pharmacy brand in Zhejiang province, China. Framing the relaunch of China Jo-Jo's corporate website, the refresh is in line with the Company's renewed business momentum as a result of China's encouragement of online pharmacy expansion in 2015.

As China continues its aggressive push to reform its healthcare system, competitive pricing and broad public access to drug dispensary services will remain top agendas driving China Jo-Jo's strategic initiatives including increased market following, profitability and critical mass in additional online pharmacy sales.

We expect the newly relaunched website to provide investors with the open transparency and insights needed to better understand China Jo-Jo's growth strategies as well as general corporate and financial information. It will be our goal to increase engagement with the markets and hope to provide future updates and enhancement to the relaunched website as our story develops alongside the rapid reforms in China that are meant to provide its citizens equal and greater access to healthcare.

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc., through its own retail drugstores, wholesale distributor and online pharmacy, is a leading retailer and wholesale distributor of pharmaceutical and healthcare products in China. As of September 30, 2015, the Company had 59 retail pharmacies in Zhejiang Province, China. The Company's wholesale subsidiary not only supplies its retail stores, but also distributes drug and other healthcare products to other drugstores and drug vendors. The Company routinely posts important information on its corporate websites at (Chinese) and (English).

Forward Looking Statement

Statements in this press release regarding the Company that are not historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "estimate," "may," "will," "should," "project," "plan," "seek," "intend," "anticipate," the negatives thereof, or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. It is routine for the Company's internal projections and expectations to change as the quarter and year progresses, and therefore it should be clearly understood that the internal projections and beliefs upon which the Company bases its expectations may change. Although these expectations may change, the Company is under no obligation to inform you if they do. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of numerous factors, including the risks associated with the effect of changing economic conditions in the People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products. Readers are referred to the reports and documents filed from time to time by the Company with the Securities and Exchange Commission for a discussion of these and other important risk factors that could cause actual results to differ from those discussed in forward-looking statements. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Investor Relations Contact:
Christopher Chu, Taylor Rafferty
Tel: (908) 251-9869

Company Contact in U.S.:
Steve Liu

To view the original version on PR Newswire, visit:

Source: China Jo-Jo Drugstores, Inc.